Abbott India launches vaccine against 4 strains of influenza virus1 min read . Updated: 24 Feb 2020, 04:56 PM IST
- An inactivated influenza vaccine is beneficial in high risk population
- It can be given to a larger set of people, and immunocompromised patients
NEW DELHI : Abbott India on Monday announced the launch of an inactivated vaccine in India against four strains of influenza virus.
“It is the only 0.5 ml quadrivalent flu vaccine in India that has been approved for use in children below 3 years. In fact, it can be given to children from 6 months onwards, and to adults," the company said in a statement.
An inactivated influenza vaccine is beneficial in high risk population, since it can be given to a larger set of people, such as pregnant women, children below 2 years, older adults and immunocompromised patients, the company said.
“We are excited with the launch of the quadrivalent version of our flu vaccine, which can be offered to both children above 6 months and adults. This particular type of vaccine provides good immune response with less side-effects," Abbott India medical director Srirupa Das was quoted as saying in the release.
Quoting a recently published study Abbott India claimed that the tetravalent vaccine demonstrated immune response compared with the some B-strains trivalent vaccines against influenza, with comparable safety.
Influenza A and B are the two strains of viruses that cause human disease, with B strain of viruses estimated to be associated with 25% of all influenza related mortality, as per the release.